CASP3 and myeloid leukemia: In a cell culture-based study, apigenin synergistically increased the sensitivity of lymphoid and myeloid leukaemia cells to the CYCLO by decreasing ATP and glutathione levels and increasing the activity of caspase 3, caspase 8, and caspase 9.